ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Letter to the Editor

Cutaneous Gamma/Delta T-cell Lymphoma During Treatment with Etanercept for Rheumatoid Arthritis

doi: 10.2340/00015555-0728

Authors:

Lianne Koens, Nancy J. Senff, Maarten H. Vermeer, H. Karel Ronday, Rein Willemze and Patty M. Jansen

References

  • Valesini G, Iannuccelli C, Marocchi E, Pascoli L, Scalzi V, Di Franco M. Biological and clinical effects of anti-TNFalpha treatment. Autoimmun Rev 2007; 7: 35–41.
  • Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002; 46: 3151–3158.
  • Lourari S, Prey S, Livideanu C, Jamard B, Lamant L, Cantagrel A, et al. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-α blocking agents: two cases. J Eur Acad Dermatol Venereol 2009; 23: 967–968.
  • Mahe E, Descamps V, Grossin M, Fraitag S, Crickx B. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol 2003; 149: 170–173.
  • Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, et al. Aggressive cutaneous T-cell lymphomas after TNF-alpha blockade. J Am Acad Dermatol 2004; 51: 660–662.
  • Michot C, Costes V, Gerard-Dran D, Guillot B, Combes B, Dereure O. Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis. Br J Dermatol 2009; 160: 889–890.
  • Dauendorffer JN, Rivet J, Allard A, Bachelez H. Sezary syndrome in a patient receiving infliximab for ankylosing spondylitis. Br J Dermatol 2007; 156: 742–743.
  • Sanli H, Ataman S, Akay BN, Yilmaz A, Yildizlar D, Gürgey E. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy. J Drugs Dermatol 2007; 6: 834–836.
  • Dalle S, Balme B, Berger F, Hayette S, Thomas L. Mycosis fungoides-associated follicular mucinosis under adalimumab. Br J Dermatol 2005; 153: 207–208
  • Bucher C, Degen L, Dirnhofer S, Pless M, Herrmann R, Schraml P, et al. Biologics in inflammatory disease: infliximab associated risk of lymphoma development. Gut 2005; 54: 732–733.
  • Lafaille P, Bouffard D, Provost N. Exacerbation of undiagnosed mycosis fungoides during treatment with etanercept. Arch Dermatol 2009; 145: 94–95.
  • Gaulard P, Berti E, Willemze R, Jaffe ES. Primary cutaneous peripheral T-cell lymphomas, rare subtypes. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008, p. 302–303.
  • Jaffe ES, Ralfkiaer E. Subcutaneous panniculitis-like T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and tumours of haematopoietic and lymphoid tissue. Lyon: IARC Press; 2001, p. 212–213.
  • Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354–371.
  • Willemze R, Jansen P, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification and prognostic factors. An EORTC cutaneous lymphoma group study of 83 cases. Blood 2008; 111: 838–845.
  • Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 2007; 56: 1433–1439.
  • Beyer M, Steinhoff M, Anagnostopoulos I, Assaf C, Sterry W. Hepatosplenic T-cell lymphomas and therapy with TNF-α-blocking biologics: a risk for psoriasis patients? J Dtsch Dermatol Ges 2009; 7: 191–194.
  • Related articles

    There are no related articles.


    Share with your friends





    Actions


    Abstract

    Full text

    PDF

    Supplementary


    There is no supplementary for this article.

    Print information


    Volume 89, Issue 6

    DOI: 10.2340/00015555-0728

    Pages: 653-654

    View at PubMed